GlassScriptPhysician profile
Michael Roger Wiedmer
NPI 1225027790
$581.05
in general payments reported to CMS, 2019-2025
12 companies · $97.30 in 2025
The $97.30 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.81 · 2021: $134 · 2022: $119 · 2023: $43.07 · 2024: $163 · 2025: $97.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $161.41 | 2019-2024 | Surgiflo Hemostatic Matrix, Ethicon, Stratafix |
| Depuy Synthes Sales INC. | $108.94 | 2023-2025 | Truespan Orthocord, Healix Knotless Peek, Orthovisc |
| Smith+Nephew, INC. | $79.79 | 2022-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Dyonics Power II |
| Sanara Medtech INC. | $71.37 | 2021-2022 | |
| Kerecis Limited | $36.47 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $24.66 | 2021 | |
| Convatec INC. | $21.44 | 2021 | |
| Kci USA, INC. | $19.99 | 2023 | Prevena |
| Ermi LLC | $18.77 | 2025 | |
| Sanofi-Aventis U.S. LLC | $13.49 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.66 | 2022 | |
| Abbott Laboratories | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wiedmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.